[ARWR] YoY Quarter Result on 30-Sep-2020 [#Q4]

Stock
[ARWR] Arrowhead Pharmaceuticals, Inc.
Announcement Date
23-Nov-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q4]
Profit Trend
QoQ- -255.84%
YoY- -513.78%
Quarter Report
ARWR's Result
ARWR's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
Revenue 16,097 31,575 38,283 7,633 43,293 11,255 8,714 10.76%
PBT -108,990 -82,157 -63,372 -48,430 11,878 -10,759 -10,729 47.13%
Tax 2,025 3,785 2 2 174 2 2 216.71%
NP -109,679 -85,942 -63,374 -48,433 11,705 -10,761 -10,732 47.28%
Tax Rate - - - - -1.46% - - -
Total Cost 125,776 117,517 101,657 56,066 31,588 22,016 19,446 36.47%
Ratio Analysis
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
NP Margin -681.36 -272.18 -165.54 -634.53 27.04 -95.61 -123.16 32.97%
Per Share
30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 CAGR
EPS -1.02 -0.81 -0.61 -0.47 0.12 -0.12 -0.14 39.21%
EPS Diluted -1.02 -0.81 -0.61 -0.47 0.12 -0.11 -0.14 39.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.